OASIS-E All Items Instrument Available

The updated draft OASIS-E All Items Instrument is now available in the Downloads section of the OASIS Data Sets webpage. OASIS-E will be effective January 01, 2023. Please note the instrument is not yet final. Office of Management and Budget (OMB) approval is required and expected later this year. The instrument may be used for training but not as a final data set for data collection until OMB approval.

Direct link to the OASIS-E Outcome Assessment Information Set Version E (OASIS-E) (cms.gov)

 

A second version of omicron is spreading. Here's why scientists are on alert

Just as the omicron surge starts to recede in parts of the U.S., scientists have their eye on another coronavirus variant spreading rapidly in parts of Asia and Europe. It's officially called "omicron BA.2," and this week scientists detected cases of it in several U.S. states, including California, Texas and Washington.

Although BA.2 is currently rare in the U.S., scientists expect it to spread in the country over the next month. There's growing evidence that it's just as contagious as — or possibly a bit more contagious than — the first omicron variant, called "omicron BA.1."

"It could be that BA.2 does have some small advantage," says Emma Hodcroft, an epidemiologist at the University of Bern who has been tracking variants all around the world throughout the pandemic via the Nextstrain project. "BA.2 might well be, like, 1% to 3% more transmissible, or something like that."

So the big question now is, will that small difference be enough for this variant to lengthen the ongoing surge in the U.S., as it has in Denmark?

What is omicron BA.2?

You can think of BA.2 as a sibling of BA.1, Hodcroft says. They share a bunch of mutations — about 30 or so — but they also have a bunch of mutations that are unique.

"They are quite similar, but they're also different," she says. "So very much like siblings, in my opinion. Different but obviously related."

Back in November, when scientists in South Africa and Botswana discovered omicron, they didn't find just one version. They found three, called BA.1, BA.2 and BA.3 by the Phylogenetic Assignment of Named Global Outbreak Lineages at the University of Edinburgh.

The first one, BA.1, took off rapidly and spread around the world, including in the United States. And initially, it looked like BA.2 and BA.3 were weaker and less able to keep up with BA.1.

"We thought, 'OK, BA.2 is just not as fit as its sibling BA.1, and it will kind of peter out,' " Hodcroft says.

But that's not what happened — not at all...

Read Full Article

 

Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Booster Candidate

Phase 2 study of Omicron-specific booster candidate mRNA-1273.529) will include two cohorts: one including participants who received the two-dose primary series of mRNA-1273 and another including participants who received the two-dose primary series and a 50 µg booster dose of mRNA-1273

Omicron neutralization six months after the third 50 µg dose of mRNA-1273 declined, but remained detectable in all participants

CAMBRIDGE, MA / ACCESSWIRE / January 26, 2021 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the first participant has been dosed in the Phase 2 study of the Company's Omicron-specific booster candidate (mRNA-1273.529). Additionally, Moderna announced the publication of neutralizing antibody data against the Omicron variant six months following a booster dose in The New England Journal of Medicine. While Omicron neutralization had declined 6.3-fold from peak titers at day 29 post-boost, levels remained detectable in all participants. Neutralizing titers against Omicron declined more rapidly than titers against the ancestral strain of the virus (D614G) which declined 2.3-fold over the same time period.

"We are reassured by the antibody persistence against Omicron at six months after the currently authorized 50 µg booster of mRNA-1273. Nonetheless, given the long-term threat demonstrated by Omicron's immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study," said Stéphane Bancel, Chief Executive Officer of Moderna. "We are also evaluating whether to include this Omicron-specific candidate in our multivalent booster program. We will continue to share data with public health authorities to help them make evidence-based decisions on the best booster strategies against SARS-CoV-2."...

Read Full Article

 

How to Train Your Hospice Volunteers

By Barbara KarnesJanuary 25, 2022

Dear Barbara, We have added volunteers to our hospice services. How should we train them?

Start with asking them why they want to be a Hospice Volunteer. End of life brings many to our hospice doors for a variety of reasons. Family members we have just cared for while their loved one was dying are grateful and want to give back. They want to help us help others as they were helped. But not yet, their grief wound is too open. Rule of thumb for family members; wait a year then we would love to have your help.  

Some people want to be a hospice volunteer because they have a religious agenda. They want to help people see the value in a relationship with God. Being a hospice volunteer is not a place to do that. It is not a reason for working with end of life. It is not a volunteer’s job. 

A person who wants to be of service, wants to give back to the community, has some spare time on their hands, and is not overly uncomfortable with the concept of death—- this is our volunteer.

How to train hospice volunteers: 

1. First, talk about them, about their motivations, their experiences with dying and death, their concept of what happens when death comes, of an after life.

Get these beliefs, thoughts, fears, experiences, and concerns out in the open. We in hospice need to help our volunteers develop a strong mental and emotional foundation before we put them in end of life situations.

Get to know these wonderful people. Help them get to know you. They are becoming part of the hospice “family.”

2. Outline a volunteer’s role, what is expected of them. Are they comfortable with direct family and patient interactions or would they rather help with community outreach or bereavement mailings and phones calls? There are many roles to fill. Not everyone is comfortable with direct people interaction.

3. Begin end of life instructions: signs of approaching death (months, weeks, days, hours), communication and listening skills, normal grief, basics in pain at end of life, symptom management, dementia at end of life, use of oxygen, foley catheter, and positioning. Not that they will be involved in any of the above but they need to have a basic knowledge.

4. Provide agency policies, protocols, do's and don’ts of what a volunteer can do and say; how to document visits and interactions. Explain the role of the hospice team, nurses, social workers, chaplains, bereavement coordinators, and how the volunteer interacts with them.

5. I would give each volunteer a copy of my book, The Final Act of Living and the booklet You Need Care, Tooto be read as homework assignments. I would show and discuss the DVDs This Is How People Die and Care For The Caregiver.

If you are a medicare hospice you already have your volunteer program in place, medicare oversees and actually micromanages what you can and cannot do. The above is thinking outside the box. An “if I could train volunteers working with end of life—hospice, Stephen Ministries, Parish nurses, the way I wanted to, this is what I would do” blog.

Read More at BKBooks

 

Reactions to CDC Recommendation for N95 and KN95 Use

The CDC now recommends that people in the US upgrade from cloth masks to N95 and KN95s. We are seeing several reactions to this recommendation.

  • 3M now requires distributors to verify bulk sales go to businesses and healthcare providers to prevent unsavory characters from hoarding masks and price-gouging customers. 
  • The federal government will offer individual households up to three N95 masks per month through local pharmacies and community health centers. Distribution methods are still being finalized
  • We anticipate this will impact the supply chain and manufacturers' work to fulfill increased demand. Get ahead of the supply crunch.

To give you even five minutes back in your day, HHAC’s community partner, bttn, has put together COVID-19 bundles to help you save time and money on the products you need to follow a multi-layered approach to keeping your staff, patients, and communities safe. Bundle any product in the catalog with their COVID-19 tests and receive 10% off their tests (no minimum order).

Visit www.bttnusa.com

 
<< first < Prev 251 252 253 254 255 256 257 258 259 260 Next > last >>

Page 252 of 386